Hwei‐Ming Peng

1.5k total citations
37 papers, 1.2k citations indexed

About

Hwei‐Ming Peng is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hwei‐Ming Peng has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Pharmacology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hwei‐Ming Peng's work include Pharmacogenetics and Drug Metabolism (18 papers), Heat shock proteins research (12 papers) and Hormonal Regulation and Hypertension (8 papers). Hwei‐Ming Peng is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Heat shock proteins research (12 papers) and Hormonal Regulation and Hypertension (8 papers). Hwei‐Ming Peng collaborates with scholars based in United States, Australia and Canada. Hwei‐Ming Peng's co-authors include Yoshihiro Morishima, William B. Pratt, Yoichi Osawa, Minor J. Coon, Richard J. Auchus, Andrew P. Lieberman, Jason E. Gestwicki, Xinxin Ding, Kostas P. Vatsis and Adrienne M. Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hwei‐Ming Peng

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hwei‐Ming Peng United States 20 759 291 182 165 155 37 1.2k
Steven H. Olson United States 24 669 0.9× 81 0.3× 80 0.4× 101 0.6× 133 0.9× 47 1.7k
Natalia Mast United States 28 1.2k 1.6× 517 1.8× 48 0.3× 450 2.7× 140 0.9× 70 2.3k
Ryohei Miyake Japan 10 983 1.3× 62 0.2× 158 0.9× 79 0.5× 172 1.1× 11 1.5k
Peter J. Bungay United Kingdom 18 428 0.6× 83 0.3× 57 0.3× 50 0.3× 114 0.7× 35 948
William K. Chan United States 15 718 0.9× 180 0.6× 57 0.3× 31 0.2× 58 0.4× 37 1.4k
Boanerges Rubalcava Mexico 14 527 0.7× 85 0.3× 86 0.5× 189 1.1× 114 0.7× 25 1.2k
G. Defaye France 22 725 1.0× 129 0.4× 97 0.5× 577 3.5× 76 0.5× 61 1.5k
Barbara Becattini Sweden 19 1.2k 1.5× 44 0.2× 135 0.7× 118 0.7× 128 0.8× 32 1.9k
Gareth Waldron United Kingdom 14 602 0.8× 83 0.3× 131 0.7× 68 0.4× 232 1.5× 21 1.3k
N Ogino Japan 29 688 0.9× 207 0.7× 93 0.5× 45 0.3× 84 0.5× 118 3.1k

Countries citing papers authored by Hwei‐Ming Peng

Since Specialization
Citations

This map shows the geographic impact of Hwei‐Ming Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hwei‐Ming Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hwei‐Ming Peng more than expected).

Fields of papers citing papers by Hwei‐Ming Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hwei‐Ming Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hwei‐Ming Peng. The network helps show where Hwei‐Ming Peng may publish in the future.

Co-authorship network of co-authors of Hwei‐Ming Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Hwei‐Ming Peng. A scholar is included among the top collaborators of Hwei‐Ming Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hwei‐Ming Peng. Hwei‐Ming Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrunak, Elyse M., et al.. (2023). Human cytochrome P450 17A1 structures with metabolites of prostate cancer drug abiraterone reveal substrate-binding plasticity and a second binding site. Journal of Biological Chemistry. 299(3). 102999–102999. 15 indexed citations
2.
Im, Sang‐Choul, et al.. (2023). Bacterial expression, purification, and reconstitution of human steroid 5α-reductases in phospholipid liposomes and nanodiscs. Methods in enzymology on CD-ROM/Methods in enzymology. 689. 263–276.
3.
Peng, Hwei‐Ming, et al.. (2018). Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid. The Journal of Steroid Biochemistry and Molecular Biology. 181. 63–72. 10 indexed citations
4.
Mizrachi, Dario, Yujie Chen, Jiayan Liu, et al.. (2015). Making water-soluble integral membrane proteins in vivo using an amphipathic protein fusion strategy. Nature Communications. 6(1). 6826–6826. 25 indexed citations
5.
Peng, Hwei‐Ming, et al.. (2014). Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5. Journal of Biological Chemistry. 289(49). 33838–33849. 34 indexed citations
6.
Peng, Hwei‐Ming, et al.. (2014). A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone. The Journal of Steroid Biochemistry and Molecular Biology. 143. 1–10. 27 indexed citations
7.
Peng, Hwei‐Ming & Richard J. Auchus. (2013). Two surfaces of cytochrome b5 with major and minor contributions to CYP3A4-catalyzed steroid and nifedipine oxygenation chemistries. Archives of Biochemistry and Biophysics. 541. 53–60. 11 indexed citations
8.
Peng, Hwei‐Ming, Gary J. Jenkins, Michael Ford, et al.. (2012). Ubiquitination of Neuronal Nitric-oxide Synthase in the Calmodulin-binding Site Triggers Proteasomal Degradation of the Protein. Journal of Biological Chemistry. 287(51). 42601–42610. 10 indexed citations
9.
Wang, Adrienne M., Yoshinari Miyata, Susan Klinedinst, et al.. (2012). Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nature Chemical Biology. 9(2). 112–118. 152 indexed citations
10.
Peng, Hwei‐Ming, Yoshihiro Morishima, William B. Pratt, & Yoichi Osawa. (2011). Modulation of Heme/Substrate Binding Cleft of Neuronal Nitric-oxide Synthase (nNOS) Regulates Binding of Hsp90 and Hsp70 Proteins and nNOS Ubiquitination. Journal of Biological Chemistry. 287(2). 1556–1565. 35 indexed citations
11.
Wang, Adrienne M., Yoshihiro Morishima, Hwei‐Ming Peng, et al.. (2010). Inhibition of Hsp70 by Methylene Blue Affects Signaling Protein Function and Ubiquitination and Modulates Polyglutamine Protein Degradation. Journal of Biological Chemistry. 285(21). 15714–15723. 77 indexed citations
12.
Peng, Hwei‐Ming, et al.. (2010). C331A Mutant of Neuronal Nitric-oxide Synthase Is Labilized for Hsp70/CHIP (C Terminus of HSC70-interacting Protein)-dependent Ubiquitination. Journal of Biological Chemistry. 285(44). 33642–33651. 10 indexed citations
13.
Thomas, Monzy, Jennifer M. Harrell, Yoshihiro Morishima, et al.. (2006). Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction. Human Molecular Genetics. 15(11). 1876–1883. 72 indexed citations
14.
Vatsis, Kostas P., Hwei‐Ming Peng, & Minor J. Coon. (2004). Abolition of oxygenase function, retention of NADPH oxidase activity, and emergence of peroxidase activity upon replacement of the axial cysteine-436 ligand by histidine in cytochrome P450 2B4. Archives of Biochemistry and Biophysics. 434(1). 128–138. 15 indexed citations
15.
Peng, Hwei‐Ming, Yoshihiro Morishima, Gary J. Jenkins, et al.. (2004). Ubiquitylation of Neuronal Nitric-oxide Synthase by CHIP, a Chaperone-dependent E3 Ligase. Journal of Biological Chemistry. 279(51). 52970–52977. 64 indexed citations
16.
Vatsis, Kostas P., Hwei‐Ming Peng, & Minor J. Coon. (2002). Replacement of active-site cysteine-436 by serine converts cytochrome P450 2B4 into an NADPH oxidase with negligible monooxygenase activity. Journal of Inorganic Biochemistry. 91(4). 542–553. 46 indexed citations
17.
Peng, Hwei‐Ming & Minor J. Coon. (2000). Promoter Function and the Role of Cytokines in the Transcriptional Regulation of Rabbit CYP2E1 and CYP2E2. Archives of Biochemistry and Biophysics. 382(1). 129–137. 29 indexed citations
18.
Peng, Hwei‐Ming & Minor J. Coon. (1998). Regulation of Rabbit Cytochrome P450 2E1 Expression in HepG2 Cells by Insulin and Thyroid Hormone. Molecular Pharmacology. 54(4). 740–747. 61 indexed citations
19.
Ding, Xinxin, Hwei‐Ming Peng, & Minor J. Coon. (1992). Cytochromes P450 NMa, NMb (2G1), and LM4 (1A2) are differentially expressed during development in rabbit olfactory mucosa and liver.. Molecular Pharmacology. 42(6). 1027–1032. 20 indexed citations
20.
Ding, Xinxin, et al.. (1992). Induction of P-450 cytochromes 2E2, 1A1, and 1A2 by imidazole in neonatal rabbits.. Drug Metabolism and Disposition. 20(6). 792–796. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026